@allisonoconn Very much a thing: especially in community practices in rural areas but also common in urban hospital employed settings. Used to be an off-ramp to retirement but increasingly seeing early and mid career docs choosing this path.
People often ask how breakthroughs occur in cancer biology-often the story is more complex - the survival plot for myeloma outcomes is extraordinary - improvements come about in incremental steps - in my lifetime treatment of Myeloma has almost transformed into a curable disease
Thank you, @natashaedwin@providence, for championing #cancer#clinicaltrial access for patients who live outside of academic research hubs.
Why patients in rural areas need access to quality clinical trials: https://t.co/iWB6THZd14 #clinicalresearch
@ramit I travel with 2-3 friends with diff diet/room preferences. We book private rooms in hostels and normalize splitting up for meals or side excursions a few times on the trip. Definitely calls for a great deal of flexibility, understanding and excellent communication!
Dr @VincentRK presenting at the Spring ECOG Conference in Tampa, FL and highlighting the Major Goals of the @eaonc Myeloma committee
Prevent progression of smoldering multiple myeloma (SMM) to multiple myeloma (MM).
Improve the treatment of newly diagnosed MM through an immunotherapy-based induction and maintenance.
Improve outcomes for relapsed and refractory MM through early incorporation of bispecific antibodies and risk-adapted strategies.
Develop MRD negativity and Myeloma-specific Patient Reporteo Outcome tools as endpoints for clinical trials.
#mmsm
Elephants rare get cancer. Why?
@MrinalPatnaik explains at the @eaonc meeting.
They gave 40 copies of the p53 tumor suppressor gene. (Humans have 2 copies)
@dgermain21@joshuaafein The Nuance Dragon Ambient eXperience (DAX) is an AI powered scribe service that automatically documents patient encounters. I’m using it currently for hematology outpatients and definitely recommend!
@INizMD@jeff_sharman I’ve been a hematologist (malignant and non malignant) in group of 8-10 MDs. As long as you have good support (clinic staff) and understanding among your partners (for hospital inpatient coverage): it’s very do-able even in smaller groups.